The mu-opioid receptor gene and smoking initiation and nicotine dependence.
- Authors
- Zhang, Lan; Kendler, Kenneth S; Chen, Xiangning
- Year
- 2006
- Journal
- Behavioral and brain functions : BBF
- PMID
- 16887046
- DOI
- 10.1186/1744-9081-2-28
- PMCID
- PMC1557520
The gene encoding the mu-opioid receptor (OPRM1) is reported to be associated with a range of substance dependence. Experiments in knockout mice indicate that the mu-opioid receptor may mediate reinforcing effects of nicotine. In humans, opioid antagonist naltrexone may reduce the reinforcing effects of tobacco smoking. Additionally, the OPRM1 gene is located in a region showing linkage to nicotine dependence. The OPRM1 is thus a plausible candidate gene for smoking behavior. To investigate whether OPRM1 contributes to the susceptibility of smoking initiation and nicotine dependence, we genotyped 11 SNPs in the gene for 688 Caucasian subjects of lifetime smokers and nonsmokers. Three SNPs showed nominal significance for smoking initiation and one reached significance for nicotine dependence. The global test for three-marker (rs9479757-rs2075572-rs10485057) haplotypes was significant for smoking initiation (p = 0.0022). The same three-marker haplotype test was marginal (p = 0.0514) for nicotine dependence. These results suggest that OPRM1 may be involved in smoking initiation and nicotine dependence.
No figures extracted from this document.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder. | Kaya-AkyΓΌzlΓΌ D et al. | β | 2023 | β |
| Nicotine and opioid co-dependence: Findings from bench research to clinical trials. | Custodio L et al. | β | 2022 | β |
| Perioperative Narcotic Use and Carpal Tunnel Release: Trends, Risk Factors, and Complications. | Gause TM et al. | β | 2020 | β |
| Significant association of mu-opioid receptor 1 haplotype with tobacco smoking in healthy control subjects but not in patients with schizophrenia and alcohol dependence. | Konjevod M et al. | β | 2020 | β |
| Analyzing the pathways enriched in genes associated with nicotine dependence in the context of human protein-protein interaction network. | Hu Y et al. | β | 2019 | β |
| Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial. | Roche DJO et al. | β | 2019 | β |
| Smoking, Pain Intensity, and Opioid Consumption 1-3 Months After Major Surgery: A Retrospective Study in a Hospital-Based Transitional Pain Service. | Montbriand JJ et al. | β | 2018 | β |
| Association of opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with nicotine dependence. | Kong X et al. | β | 2017 | β |
| Genotype Γ Environment Interaction in Smoking Behaviors: A Systematic Review. | Do EK et al. | β | 2017 | β |
| Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. | Schwantes-An TH et al. | β | 2016 | β |
| Nociceptin/orphanin FQ receptor gene variation is associated with smoking status in Japanese. | Kasai S et al. | β | 2016 | β |
| Novel long chain fatty acid derivatives of quercetin-3-O-glucoside reduce cytotoxicity induced by cigarette smoke toxicants in human fetal lung fibroblasts. | Warnakulasuriya SN et al. | β | 2016 | β |
| Methadone's effect on nAChRs--a link between methadone use and smoking? | Talka R et al. | β | 2015 | β |
| Regional brain [(11)C]carfentanil binding following tobacco smoking. | Domino EF et al. | β | 2015 | β |
| A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the ΞΌ opioid receptor gene OPRM1 via hnRNPH interactions. | Xu J et al. | β | 2014 | β |
| Association between common genetic variants in the opioid pathway and smoking behaviors in Chinese men. | Fang J et al. | β | 2014 | β |
| Association of smoking with ΞΌ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects. | Weerts EM et al. | β | 2014 | β |
| Dopamine function in cigarette smokers: an [ΒΉβΈF]-DOPA PET study. | Bloomfield MA et al. | β | 2014 | β |
| Genetic, psychosocial, and demographic factors associated with social disinhibition in Mexican-origin youth. | Archer NP et al. | β | 2014 | β |
| Genetic variants and early cigarette smoking and nicotine dependence phenotypes in adolescents. | O'Loughlin J et al. | β | 2014 | β |
| Pharmacogenetics of OPRM1. | Crist RC et al. | β | 2014 | β |
| Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study. | Beer B et al. | β | 2013 | β |
| Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside? | Mura E et al. | β | 2013 | β |
| Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex. | Kleinjan M et al. | β | 2013 | β |
| ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers. | Daws SE et al. | β | 2013 | β |
| Gene-environment interaction effects on lung function- a genome-wide association study within the Framingham heart study. | Liao SY et al. | β | 2013 | β |
| Lack of association of OPRM1 genotype and smoking cessation. | MunafΓ² MR et al. | β | 2013 | β |
| Opioid receptor polymorphism A118G associated with clinical severity in a drug overdose population. | Manini AF et al. | β | 2013 | β |
| Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model. | Raffa RB et al. | β | 2013 | β |
| Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment. | Proudnikov D et al. | β | 2012 | β |
| A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation. | Verhagen M et al. | β | 2012 | β |
| Cigarette experimentation in Mexican origin youth: psychosocial and genetic determinants. | Wilkinson AV et al. | β | 2012 | β |
| Rat models of ADHD. | Sagvolden T et al. | β | 2012 | β |
| ΞΌ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief. | Falcone M et al. | β | 2012 | β |
| Nicotine withdrawal-induced negative affect is a function of nicotine dependence and not liability to depression or anxiety. | Edwards AC et al. | β | 2011 | β |
| No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample. | Nikolov MA et al. | β | 2011 | β |
| Pharmacogenomics of the human Β΅-opioid receptor. | Kasai S et al. | β | 2011 | β |
| 'Smoking genes': a genetic association study. | Verde Z et al. | β | 2011 | β |
| Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. | Wang J et al. | β | 2010 | β |
| Meta-analysis of 15 genome-wide linkage scans of smoking behavior. | Han S et al. | β | 2010 | β |
| Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. | Berrendero F et al. | β | 2010 | β |
| OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. | Mague SD et al. | β | 2010 | β |
| The Role of Genetics in Nicotine Dependence: Mapping the Pathways from Genome to Syndrome. | Mackillop J et al. | β | 2010 | β |
| Different affective response to opioid withdrawal in adolescent and adult mice. | Hodgson SR et al. | β | 2009 | β |
| Further evidence for an association between the gamma-aminobutyric acid receptor A, subunit 4 genes on chromosome 4 and FagerstrΓΆm Test for Nicotine Dependence. | Agrawal A et al. | β | 2009 | β |
| Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. | Mague SD et al. | β | 2009 | β |
| Nicotine dependence: biology, behavior, and treatment. | Ray R et al. | β | 2009 | β |
| Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample. | Hardin J et al. | β | 2009 | β |
| OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. | Oroszi G et al. | β | 2009 | β |
| The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain. | Sagvolden T et al. | β | 2009 | β |
| A comparison of molecular alterations in environmental and genetic rat models of ADHD: a pilot study. | DasBanerjee T et al. | β | 2008 | β |
| Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians. | Ehlers CL et al. | β | 2008 | β |
| Association of candidate genes with antisocial drug dependence in adolescents. | Corley RP et al. | β | 2008 | β |
| Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. | Perkins KA et al. | β | 2008 | β |
| A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin. | Kapur S et al. | β | 2007 | β |
| Association of the mu-opioid receptor gene with smoking cessation. | MunafΓ² MR et al. | β | 2007 | β |
| Endogenous opiates and behavior: 2006. | Bodnar RJ | β | 2007 | β |
| Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. | Glatt SJ et al. | β | 2007 | β |
| Genetics and smoking behavior. | Schnoll RA et al. | β | 2007 | β |
| Genetics and smoking cessation improving outcomes in smokers at risk. | Lerman CE et al. | β | 2007 | β |
| Pharmacogenetics and smoking cessation with nicotine replacement therapy. | Ray R et al. | β | 2007 | β |
| RhoA, encoding a Rho GTPase, is associated with smoking initiation. | Chen X et al. | β | 2007 | β |
| Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. | Guillem K et al. | β | 2006 | β |